nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—alcohol dependence	0.409	1	CbGaD
Alosetron—CYP2E1—Disulfiram—alcohol dependence	0.121	0.316	CbGbCtD
Alosetron—CYP2E1—Citalopram—alcohol dependence	0.0861	0.225	CbGbCtD
Alosetron—CYP2C9—Disulfiram—alcohol dependence	0.063	0.165	CbGbCtD
Alosetron—CYP1A2—Citalopram—alcohol dependence	0.0498	0.13	CbGbCtD
Alosetron—CYP3A4—Disulfiram—alcohol dependence	0.0366	0.0958	CbGbCtD
Alosetron—CYP3A4—Citalopram—alcohol dependence	0.0261	0.0682	CbGbCtD
Alosetron—Dysequilibrium—Citalopram—alcohol dependence	0.00837	0.0643	CcSEcCtD
Alosetron—Gastrointestinal infection—Citalopram—alcohol dependence	0.00446	0.0342	CcSEcCtD
Alosetron—Respiration abnormal—Citalopram—alcohol dependence	0.00367	0.0282	CcSEcCtD
Alosetron—HTR3A—Ligand-gated ion channel transport—GABRB1—alcohol dependence	0.00338	0.052	CbGpPWpGaD
Alosetron—Muscle stiffness—Citalopram—alcohol dependence	0.00315	0.0241	CcSEcCtD
Alosetron—HTR3A—Ligand-gated ion channel transport—GABRA2—alcohol dependence	0.00287	0.0442	CbGpPWpGaD
Alosetron—Dermatitis atopic—Disulfiram—alcohol dependence	0.00276	0.0212	CcSEcCtD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00245	0.0377	CbGpPWpGaD
Alosetron—Ondansetron—OPRM1—alcohol dependence	0.00242	0.427	CrCbGaD
Alosetron—Proctocolitis—Citalopram—alcohol dependence	0.00239	0.0183	CcSEcCtD
Alosetron—Colitis ulcerative—Citalopram—alcohol dependence	0.00239	0.0183	CcSEcCtD
Alosetron—Tenderness—Disulfiram—alcohol dependence	0.00234	0.018	CcSEcCtD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00203	0.0312	CbGpPWpGaD
Alosetron—Skin infection—Citalopram—alcohol dependence	0.002	0.0153	CcSEcCtD
Alosetron—Ondansetron—HTR1B—alcohol dependence	0.00198	0.348	CrCbGaD
Alosetron—Diuresis—Citalopram—alcohol dependence	0.00195	0.0149	CcSEcCtD
Alosetron—Muscle rigidity—Naltrexone—alcohol dependence	0.00186	0.0143	CcSEcCtD
Alosetron—Diverticulitis—Citalopram—alcohol dependence	0.00185	0.0142	CcSEcCtD
Alosetron—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00178	0.0273	CbGpPWpGaD
Alosetron—Cholecystitis—Acamprosate—alcohol dependence	0.00175	0.0134	CcSEcCtD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00173	0.0266	CbGpPWpGaD
Alosetron—Haemorrhoids—Naltrexone—alcohol dependence	0.00162	0.0124	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00147	0.0227	CbGpPWpGaD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00147	0.0226	CbGpPWpGaD
Alosetron—HTR3A—nerve—alcohol dependence	0.00137	0.169	CbGeAlD
Alosetron—Laryngitis—Naltrexone—alcohol dependence	0.00132	0.0101	CcSEcCtD
Alosetron—CYP2E1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00129	0.0199	CbGpPWpGaD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00129	0.0198	CbGpPWpGaD
Alosetron—Ondansetron—CYP2E1—alcohol dependence	0.00128	0.225	CrCbGaD
Alosetron—Trauma—Citalopram—alcohol dependence	0.00127	0.00972	CcSEcCtD
Alosetron—Abdominal discomfort—Disulfiram—alcohol dependence	0.00123	0.00943	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00122	0.0188	CbGpPWpGaD
Alosetron—Muscle rigidity—Citalopram—alcohol dependence	0.00118	0.00905	CcSEcCtD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00114	0.0175	CbGpPWpGaD
Alosetron—Jaundice—Disulfiram—alcohol dependence	0.00111	0.00855	CcSEcCtD
Alosetron—Balance disorder—Citalopram—alcohol dependence	0.0011	0.00847	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Naltrexone—alcohol dependence	0.00106	0.00814	CcSEcCtD
Alosetron—Cholecystitis—Citalopram—alcohol dependence	0.00105	0.00806	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00104	0.016	CbGpPWpGaD
Alosetron—Haemorrhoids—Citalopram—alcohol dependence	0.00103	0.00787	CcSEcCtD
Alosetron—Hepatitis—Disulfiram—alcohol dependence	0.00103	0.00787	CcSEcCtD
Alosetron—Hypoaesthesia—Disulfiram—alcohol dependence	0.00102	0.00783	CcSEcCtD
Alosetron—Ulcer—Naltrexone—alcohol dependence	0.00101	0.00772	CcSEcCtD
Alosetron—Abnormal dreams—Acamprosate—alcohol dependence	0.000994	0.00763	CcSEcCtD
Alosetron—Colitis—Acamprosate—alcohol dependence	0.000966	0.00741	CcSEcCtD
Alosetron—Haematoma—Citalopram—alcohol dependence	0.000959	0.00736	CcSEcCtD
Alosetron—Folliculitis—Citalopram—alcohol dependence	0.000959	0.00736	CcSEcCtD
Alosetron—Respiratory tract infection—Citalopram—alcohol dependence	0.000959	0.00736	CcSEcCtD
Alosetron—Blood pressure increased—Naltrexone—alcohol dependence	0.000952	0.00731	CcSEcCtD
Alosetron—Photophobia—Acamprosate—alcohol dependence	0.000944	0.00725	CcSEcCtD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.000942	0.0145	CbGpPWpGaD
Alosetron—Abnormal dreams—Naltrexone—alcohol dependence	0.000941	0.00722	CcSEcCtD
Alosetron—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.00092	0.0142	CbGpPWpGaD
Alosetron—Colitis—Naltrexone—alcohol dependence	0.000914	0.00701	CcSEcCtD
Alosetron—Urine output increased—Acamprosate—alcohol dependence	0.000909	0.00698	CcSEcCtD
Alosetron—CYP2E1—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000907	0.014	CbGpPWpGaD
Alosetron—Menstrual disorder—Citalopram—alcohol dependence	0.000885	0.00679	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.000882	0.0136	CbGpPWpGaD
Alosetron—Burning sensation—Citalopram—alcohol dependence	0.000868	0.00666	CcSEcCtD
Alosetron—Laryngitis—Citalopram—alcohol dependence	0.000837	0.00642	CcSEcCtD
Alosetron—Polyuria—Acamprosate—alcohol dependence	0.000832	0.00638	CcSEcCtD
Alosetron—Gastroenteritis—Acamprosate—alcohol dependence	0.000824	0.00632	CcSEcCtD
Alosetron—Dermatitis atopic—Citalopram—alcohol dependence	0.000815	0.00625	CcSEcCtD
Alosetron—Eczema—Acamprosate—alcohol dependence	0.000812	0.00624	CcSEcCtD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.000801	0.0123	CbGpPWpGaD
Alosetron—Sleep disorder—Naltrexone—alcohol dependence	0.000798	0.00613	CcSEcCtD
Alosetron—Injury—Acamprosate—alcohol dependence	0.000794	0.0061	CcSEcCtD
Alosetron—CYP2E1—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.000783	0.012	CbGpPWpGaD
Alosetron—Fungal infection—Citalopram—alcohol dependence	0.000781	0.00599	CcSEcCtD
Alosetron—Gastroenteritis—Naltrexone—alcohol dependence	0.000779	0.00598	CcSEcCtD
Alosetron—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000776	0.0119	CbGpPWpGaD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000774	0.0119	CbGpPWpGaD
Alosetron—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000737	0.0113	CbGpPWpGaD
Alosetron—HTR3A—Ion channel transport—GABRB1—alcohol dependence	0.000734	0.0113	CbGpPWpGaD
Alosetron—Acne—Citalopram—alcohol dependence	0.000717	0.0055	CcSEcCtD
Alosetron—Extrasystoles—Citalopram—alcohol dependence	0.000717	0.0055	CcSEcCtD
Alosetron—Contusion—Citalopram—alcohol dependence	0.000691	0.00531	CcSEcCtD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00069	0.0106	CbGpPWpGaD
Alosetron—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.000688	0.0106	CbGpPWpGaD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.000681	0.0105	CbGpPWpGaD
Alosetron—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.000672	0.00516	CcSEcCtD
Alosetron—Drug interaction—Citalopram—alcohol dependence	0.00065	0.00499	CcSEcCtD
Alosetron—Gastritis—Acamprosate—alcohol dependence	0.000646	0.00496	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.000644	0.00494	CcSEcCtD
Alosetron—Abdominal distension—Acamprosate—alcohol dependence	0.000635	0.00488	CcSEcCtD
Alosetron—Abdominal pain upper—Naltrexone—alcohol dependence	0.000631	0.00484	CcSEcCtD
Alosetron—Bone pain—Citalopram—alcohol dependence	0.000629	0.00483	CcSEcCtD
Alosetron—Fatigue—Disulfiram—alcohol dependence	0.000628	0.00482	CcSEcCtD
Alosetron—HTR3A—Ion channel transport—GABRA2—alcohol dependence	0.000624	0.0096	CbGpPWpGaD
Alosetron—Pain—Disulfiram—alcohol dependence	0.000623	0.00478	CcSEcCtD
Alosetron—Cramp muscle—Naltrexone—alcohol dependence	0.000622	0.00478	CcSEcCtD
Alosetron—Nasopharyngitis—Naltrexone—alcohol dependence	0.000618	0.00474	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000609	0.00468	CcSEcCtD
Alosetron—Blood pressure increased—Citalopram—alcohol dependence	0.000603	0.00463	CcSEcCtD
Alosetron—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000599	0.00922	CbGpPWpGaD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000597	0.00919	CbGpPWpGaD
Alosetron—Abnormal dreams—Citalopram—alcohol dependence	0.000596	0.00457	CcSEcCtD
Alosetron—Cystitis noninfective—Citalopram—alcohol dependence	0.000589	0.00452	CcSEcCtD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.000588	0.00905	CbGpPWpGaD
Alosetron—HTR3A—brainstem—alcohol dependence	0.000586	0.0727	CbGeAlD
Alosetron—Pollakiuria—Acamprosate—alcohol dependence	0.000583	0.00448	CcSEcCtD
Alosetron—Cystitis—Citalopram—alcohol dependence	0.000582	0.00447	CcSEcCtD
Alosetron—Colitis—Citalopram—alcohol dependence	0.000579	0.00444	CcSEcCtD
Alosetron—Abdominal discomfort—Naltrexone—alcohol dependence	0.000572	0.00439	CcSEcCtD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000572	0.0088	CbGpPWpGaD
Alosetron—Hyperglycaemia—Acamprosate—alcohol dependence	0.000569	0.00437	CcSEcCtD
Alosetron—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000569	0.00876	CbGpPWpGaD
Alosetron—Photophobia—Citalopram—alcohol dependence	0.000566	0.00435	CcSEcCtD
Alosetron—HTR3A—forebrain—alcohol dependence	0.000566	0.0702	CbGeAlD
Alosetron—Depression—Acamprosate—alcohol dependence	0.000561	0.00431	CcSEcCtD
Alosetron—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000555	0.00426	CcSEcCtD
Alosetron—Urinary tract infection—Acamprosate—alcohol dependence	0.000547	0.0042	CcSEcCtD
Alosetron—Urine output increased—Citalopram—alcohol dependence	0.000545	0.00419	CcSEcCtD
Alosetron—Bladder pain—Citalopram—alcohol dependence	0.000545	0.00419	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000545	0.00839	CbGpPWpGaD
Alosetron—Sweating—Acamprosate—alcohol dependence	0.000539	0.00414	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000539	0.00829	CbGpPWpGaD
Alosetron—Depression—Naltrexone—alcohol dependence	0.000531	0.00408	CcSEcCtD
Alosetron—Asthenia—Disulfiram—alcohol dependence	0.000523	0.00401	CcSEcCtD
Alosetron—Urinary tract infection—Naltrexone—alcohol dependence	0.000517	0.00397	CcSEcCtD
Alosetron—Haemoglobin—Acamprosate—alcohol dependence	0.000508	0.0039	CcSEcCtD
Alosetron—Sleep disorder—Citalopram—alcohol dependence	0.000506	0.00388	CcSEcCtD
Alosetron—Haemorrhage—Acamprosate—alcohol dependence	0.000505	0.00388	CcSEcCtD
Alosetron—Hepatitis—Acamprosate—alcohol dependence	0.000505	0.00388	CcSEcCtD
Alosetron—Hypoaesthesia—Acamprosate—alcohol dependence	0.000503	0.00386	CcSEcCtD
Alosetron—Sinusitis—Naltrexone—alcohol dependence	0.000499	0.00383	CcSEcCtD
Alosetron—Polyuria—Citalopram—alcohol dependence	0.000498	0.00383	CcSEcCtD
Alosetron—Gastroenteritis—Citalopram—alcohol dependence	0.000494	0.00379	CcSEcCtD
Alosetron—Eczema—Citalopram—alcohol dependence	0.000487	0.00374	CcSEcCtD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000486	0.00748	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000485	0.00747	CbGpPWpGaD
Alosetron—Hepatitis—Naltrexone—alcohol dependence	0.000478	0.00367	CcSEcCtD
Alosetron—Injury—Citalopram—alcohol dependence	0.000476	0.00366	CcSEcCtD
Alosetron—Rash—Disulfiram—alcohol dependence	0.000459	0.00353	CcSEcCtD
Alosetron—CYP2E1—Tryptophan metabolism—MAOB—alcohol dependence	0.000458	0.00705	CbGpPWpGaD
Alosetron—Headache—Disulfiram—alcohol dependence	0.000456	0.0035	CcSEcCtD
Alosetron—Hypoglycaemia—Citalopram—alcohol dependence	0.000449	0.00344	CcSEcCtD
Alosetron—Alopecia—Acamprosate—alcohol dependence	0.000446	0.00343	CcSEcCtD
Alosetron—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000436	0.00671	CbGpPWpGaD
Alosetron—Flatulence—Acamprosate—alcohol dependence	0.000433	0.00333	CcSEcCtD
Alosetron—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.000427	0.00656	CbGpPWpGaD
Alosetron—Muscle spasms—Acamprosate—alcohol dependence	0.000423	0.00325	CcSEcCtD
Alosetron—Alopecia—Naltrexone—alcohol dependence	0.000422	0.00324	CcSEcCtD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000421	0.00647	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000415	0.00638	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000413	0.00636	CbGpPWpGaD
Alosetron—Tremor—Acamprosate—alcohol dependence	0.000412	0.00316	CcSEcCtD
Alosetron—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00041	0.00631	CbGpPWpGaD
Alosetron—Flatulence—Naltrexone—alcohol dependence	0.00041	0.00315	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000408	0.00629	CbGpPWpGaD
Alosetron—Ill-defined disorder—Acamprosate—alcohol dependence	0.000408	0.00313	CcSEcCtD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000402	0.00619	CbGpPWpGaD
Alosetron—Muscle spasms—Naltrexone—alcohol dependence	0.0004	0.00307	CcSEcCtD
Alosetron—Abdominal pain upper—Citalopram—alcohol dependence	0.0004	0.00307	CcSEcCtD
Alosetron—HTR3A—digestive system—alcohol dependence	0.000397	0.0493	CbGeAlD
Alosetron—Malaise—Acamprosate—alcohol dependence	0.000397	0.00304	CcSEcCtD
Alosetron—Cramp muscle—Citalopram—alcohol dependence	0.000394	0.00303	CcSEcCtD
Alosetron—Nasopharyngitis—Citalopram—alcohol dependence	0.000391	0.003	CcSEcCtD
Alosetron—Tremor—Naltrexone—alcohol dependence	0.00039	0.00299	CcSEcCtD
Alosetron—CYP2E1—Tryptophan metabolism—ALDH2—alcohol dependence	0.00039	0.006	CbGpPWpGaD
Alosetron—Gastritis—Citalopram—alcohol dependence	0.000387	0.00297	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000386	0.00296	CcSEcCtD
Alosetron—Ill-defined disorder—Naltrexone—alcohol dependence	0.000386	0.00296	CcSEcCtD
Alosetron—Cough—Acamprosate—alcohol dependence	0.000384	0.00295	CcSEcCtD
Alosetron—Abdominal distension—Citalopram—alcohol dependence	0.000381	0.00292	CcSEcCtD
Alosetron—Hypertension—Acamprosate—alcohol dependence	0.00038	0.00291	CcSEcCtD
Alosetron—HTR3A—blood—alcohol dependence	0.000378	0.0469	CbGeAlD
Alosetron—Malaise—Naltrexone—alcohol dependence	0.000375	0.00288	CcSEcCtD
Alosetron—Myalgia—Acamprosate—alcohol dependence	0.000374	0.00287	CcSEcCtD
Alosetron—Anxiety—Acamprosate—alcohol dependence	0.000373	0.00286	CcSEcCtD
Alosetron—Discomfort—Acamprosate—alcohol dependence	0.00037	0.00284	CcSEcCtD
Alosetron—CYP2E1—Biological oxidations—ADH6—alcohol dependence	0.000366	0.00564	CbGpPWpGaD
Alosetron—Dry mouth—Acamprosate—alcohol dependence	0.000366	0.00281	CcSEcCtD
Alosetron—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000365	0.00561	CbGpPWpGaD
Alosetron—Cough—Naltrexone—alcohol dependence	0.000363	0.00279	CcSEcCtD
Alosetron—Abdominal discomfort—Citalopram—alcohol dependence	0.000363	0.00278	CcSEcCtD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000362	0.00558	CbGpPWpGaD
Alosetron—Confusional state—Acamprosate—alcohol dependence	0.000362	0.00278	CcSEcCtD
Alosetron—Hypertension—Naltrexone—alcohol dependence	0.000359	0.00276	CcSEcCtD
Alosetron—Infection—Acamprosate—alcohol dependence	0.000357	0.00274	CcSEcCtD
Alosetron—Myalgia—Naltrexone—alcohol dependence	0.000354	0.00272	CcSEcCtD
Alosetron—Anxiety—Naltrexone—alcohol dependence	0.000353	0.00271	CcSEcCtD
Alosetron—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000352	0.0027	CcSEcCtD
Alosetron—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000351	0.00539	CbGpPWpGaD
Alosetron—Discomfort—Naltrexone—alcohol dependence	0.00035	0.00269	CcSEcCtD
Alosetron—Pollakiuria—Citalopram—alcohol dependence	0.000349	0.00268	CcSEcCtD
Alosetron—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000349	0.00537	CbGpPWpGaD
Alosetron—Skin disorder—Acamprosate—alcohol dependence	0.000349	0.00268	CcSEcCtD
Alosetron—Hyperhidrosis—Acamprosate—alcohol dependence	0.000347	0.00266	CcSEcCtD
Alosetron—Dry mouth—Naltrexone—alcohol dependence	0.000346	0.00266	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000344	0.00529	CbGpPWpGaD
Alosetron—Confusional state—Naltrexone—alcohol dependence	0.000342	0.00263	CcSEcCtD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000342	0.00526	CbGpPWpGaD
Alosetron—Hyperglycaemia—Citalopram—alcohol dependence	0.000341	0.00262	CcSEcCtD
Alosetron—Infection—Naltrexone—alcohol dependence	0.000337	0.00259	CcSEcCtD
Alosetron—Depression—Citalopram—alcohol dependence	0.000336	0.00258	CcSEcCtD
Alosetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000336	0.00518	CbGpPWpGaD
Alosetron—Skin disorder—Naltrexone—alcohol dependence	0.00033	0.00253	CcSEcCtD
Alosetron—Jaundice—Citalopram—alcohol dependence	0.000329	0.00252	CcSEcCtD
Alosetron—Hyperhidrosis—Naltrexone—alcohol dependence	0.000328	0.00252	CcSEcCtD
Alosetron—Urinary tract infection—Citalopram—alcohol dependence	0.000328	0.00252	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000327	0.00251	CcSEcCtD
Alosetron—Sweating—Citalopram—alcohol dependence	0.000323	0.00248	CcSEcCtD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00032	0.00493	CbGpPWpGaD
Alosetron—Sinusitis—Citalopram—alcohol dependence	0.000316	0.00243	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000309	0.00237	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000307	0.00473	CbGpPWpGaD
Alosetron—HTR3A—nervous system—alcohol dependence	0.000307	0.0381	CbGeAlD
Alosetron—Pain—Acamprosate—alcohol dependence	0.000307	0.00236	CcSEcCtD
Alosetron—Constipation—Acamprosate—alcohol dependence	0.000307	0.00236	CcSEcCtD
Alosetron—Haemoglobin—Citalopram—alcohol dependence	0.000304	0.00234	CcSEcCtD
Alosetron—CYP2E1—Biological oxidations—ADH1A—alcohol dependence	0.000304	0.00467	CbGpPWpGaD
Alosetron—Hepatitis—Citalopram—alcohol dependence	0.000303	0.00232	CcSEcCtD
Alosetron—Haemorrhage—Citalopram—alcohol dependence	0.000303	0.00232	CcSEcCtD
Alosetron—Hypoaesthesia—Citalopram—alcohol dependence	0.000301	0.00231	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000301	0.00463	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0003	0.00462	CbGpPWpGaD
Alosetron—Feeling abnormal—Acamprosate—alcohol dependence	0.000296	0.00227	CcSEcCtD
Alosetron—HTR3A—central nervous system—alcohol dependence	0.000296	0.0367	CbGeAlD
Alosetron—Fatigue—Naltrexone—alcohol dependence	0.000293	0.00225	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000292	0.0045	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000291	0.00447	CbGpPWpGaD
Alosetron—Pain—Naltrexone—alcohol dependence	0.00029	0.00223	CcSEcCtD
Alosetron—Constipation—Naltrexone—alcohol dependence	0.00029	0.00223	CcSEcCtD
Alosetron—Urticaria—Acamprosate—alcohol dependence	0.000285	0.00219	CcSEcCtD
Alosetron—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000281	0.00433	CbGpPWpGaD
Alosetron—Feeling abnormal—Naltrexone—alcohol dependence	0.00028	0.00215	CcSEcCtD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000279	0.00429	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000275	0.00424	CbGpPWpGaD
Alosetron—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000271	0.00416	CbGpPWpGaD
Alosetron—Arrhythmia—Citalopram—alcohol dependence	0.000271	0.00208	CcSEcCtD
Alosetron—Urticaria—Naltrexone—alcohol dependence	0.00027	0.00207	CcSEcCtD
Alosetron—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000269	0.00414	CbGpPWpGaD
Alosetron—Alopecia—Citalopram—alcohol dependence	0.000268	0.00205	CcSEcCtD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000265	0.00408	CbGpPWpGaD
Alosetron—Hypersensitivity—Acamprosate—alcohol dependence	0.000264	0.00203	CcSEcCtD
Alosetron—Flatulence—Citalopram—alcohol dependence	0.00026	0.00199	CcSEcCtD
Alosetron—CYP2E1—Biological oxidations—ADH4—alcohol dependence	0.000258	0.00397	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000258	0.00397	CbGpPWpGaD
Alosetron—Asthenia—Acamprosate—alcohol dependence	0.000257	0.00198	CcSEcCtD
Alosetron—HTR3A—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000255	0.00393	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000255	0.00393	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000255	0.00392	CbGpPWpGaD
Alosetron—Muscle spasms—Citalopram—alcohol dependence	0.000253	0.00195	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000251	0.00386	CbGpPWpGaD
Alosetron—Hypersensitivity—Naltrexone—alcohol dependence	0.00025	0.00192	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000248	0.00382	CbGpPWpGaD
Alosetron—Tremor—Citalopram—alcohol dependence	0.000247	0.0019	CcSEcCtD
Alosetron—Ill-defined disorder—Citalopram—alcohol dependence	0.000245	0.00188	CcSEcCtD
Alosetron—Asthenia—Naltrexone—alcohol dependence	0.000244	0.00187	CcSEcCtD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000238	0.00367	CbGpPWpGaD
Alosetron—Malaise—Citalopram—alcohol dependence	0.000238	0.00182	CcSEcCtD
Alosetron—HTR3A—brain—alcohol dependence	0.000235	0.0291	CbGeAlD
Alosetron—CYP2C9—cardiovascular system—alcohol dependence	0.000234	0.0291	CbGeAlD
Alosetron—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000234	0.0036	CbGpPWpGaD
Alosetron—Cough—Citalopram—alcohol dependence	0.00023	0.00177	CcSEcCtD
Alosetron—Vomiting—Acamprosate—alcohol dependence	0.000228	0.00175	CcSEcCtD
Alosetron—Hypertension—Citalopram—alcohol dependence	0.000228	0.00175	CcSEcCtD
Alosetron—Rash—Acamprosate—alcohol dependence	0.000226	0.00174	CcSEcCtD
Alosetron—Dermatitis—Acamprosate—alcohol dependence	0.000226	0.00174	CcSEcCtD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000226	0.00347	CbGpPWpGaD
Alosetron—Headache—Acamprosate—alcohol dependence	0.000225	0.00173	CcSEcCtD
Alosetron—Myalgia—Citalopram—alcohol dependence	0.000224	0.00172	CcSEcCtD
Alosetron—Anxiety—Citalopram—alcohol dependence	0.000224	0.00172	CcSEcCtD
Alosetron—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000223	0.00343	CbGpPWpGaD
Alosetron—CYP2E1—cardiovascular system—alcohol dependence	0.000222	0.0275	CbGeAlD
Alosetron—Discomfort—Citalopram—alcohol dependence	0.000222	0.0017	CcSEcCtD
Alosetron—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.00022	0.00339	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—ADH7—alcohol dependence	0.00022	0.00338	CbGpPWpGaD
Alosetron—Dry mouth—Citalopram—alcohol dependence	0.000219	0.00168	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000218	0.00335	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000217	0.00334	CbGpPWpGaD
Alosetron—Confusional state—Citalopram—alcohol dependence	0.000217	0.00167	CcSEcCtD
Alosetron—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000216	0.00333	CbGpPWpGaD
Alosetron—Vomiting—Naltrexone—alcohol dependence	0.000216	0.00166	CcSEcCtD
Alosetron—Rash—Naltrexone—alcohol dependence	0.000214	0.00164	CcSEcCtD
Alosetron—Dermatitis—Naltrexone—alcohol dependence	0.000214	0.00164	CcSEcCtD
Alosetron—Infection—Citalopram—alcohol dependence	0.000214	0.00164	CcSEcCtD
Alosetron—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000214	0.00329	CbGpPWpGaD
Alosetron—Nausea—Acamprosate—alcohol dependence	0.000213	0.00164	CcSEcCtD
Alosetron—Headache—Naltrexone—alcohol dependence	0.000213	0.00163	CcSEcCtD
Alosetron—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000213	0.00327	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000211	0.00325	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GGT2—alcohol dependence	0.00021	0.00324	CbGpPWpGaD
Alosetron—Skin disorder—Citalopram—alcohol dependence	0.000209	0.0016	CcSEcCtD
Alosetron—Hyperhidrosis—Citalopram—alcohol dependence	0.000208	0.0016	CcSEcCtD
Alosetron—CYP1A2—digestive system—alcohol dependence	0.000205	0.0254	CbGeAlD
Alosetron—Nausea—Naltrexone—alcohol dependence	0.000202	0.00155	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000196	0.0015	CcSEcCtD
Alosetron—CYP1A2—blood—alcohol dependence	0.000195	0.0242	CbGeAlD
Alosetron—CYP2C9—digestive system—alcohol dependence	0.000194	0.0241	CbGeAlD
Alosetron—CYP2E1—Biological oxidations—ADH1B—alcohol dependence	0.000193	0.00296	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000192	0.00295	CbGpPWpGaD
Alosetron—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000188	0.0029	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000187	0.00288	CbGpPWpGaD
Alosetron—Fatigue—Citalopram—alcohol dependence	0.000185	0.00142	CcSEcCtD
Alosetron—CYP2C9—blood—alcohol dependence	0.000185	0.023	CbGeAlD
Alosetron—CYP2E1—digestive system—alcohol dependence	0.000184	0.0229	CbGeAlD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000184	0.00283	CbGpPWpGaD
Alosetron—Constipation—Citalopram—alcohol dependence	0.000184	0.00141	CcSEcCtD
Alosetron—Pain—Citalopram—alcohol dependence	0.000184	0.00141	CcSEcCtD
Alosetron—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000183	0.00281	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000182	0.0028	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000181	0.00278	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000181	0.00278	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00018	0.00276	CbGpPWpGaD
Alosetron—Feeling abnormal—Citalopram—alcohol dependence	0.000177	0.00136	CcSEcCtD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000177	0.00273	CbGpPWpGaD
Alosetron—CYP2E1—blood—alcohol dependence	0.000176	0.0218	CbGeAlD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000175	0.00269	CbGpPWpGaD
Alosetron—Urticaria—Citalopram—alcohol dependence	0.000171	0.00131	CcSEcCtD
Alosetron—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.00017	0.00262	CbGpPWpGaD
Alosetron—CYP1A2—endocrine gland—alcohol dependence	0.000169	0.021	CbGeAlD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000168	0.00259	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000168	0.00258	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000161	0.00247	CbGpPWpGaD
Alosetron—CYP2C9—endocrine gland—alcohol dependence	0.000161	0.0199	CbGeAlD
Alosetron—CYP2E1—Biological oxidations—MAOB—alcohol dependence	0.00016	0.00245	CbGpPWpGaD
Alosetron—Hypersensitivity—Citalopram—alcohol dependence	0.000159	0.00122	CcSEcCtD
Alosetron—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000155	0.00239	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000154	0.00238	CbGpPWpGaD
Alosetron—Asthenia—Citalopram—alcohol dependence	0.000154	0.00118	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000153	0.00236	CbGpPWpGaD
Alosetron—CYP1A2—liver—alcohol dependence	0.000153	0.0189	CbGeAlD
Alosetron—CYP2E1—endocrine gland—alcohol dependence	0.000152	0.0189	CbGeAlD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000151	0.00233	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000149	0.0023	CbGpPWpGaD
Alosetron—CYP3A4—digestive system—alcohol dependence	0.000148	0.0184	CbGeAlD
Alosetron—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000148	0.00228	CbGpPWpGaD
Alosetron—CYP2E1—testis—alcohol dependence	0.000145	0.018	CbGeAlD
Alosetron—CYP2C9—liver—alcohol dependence	0.000145	0.018	CbGeAlD
Alosetron—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000144	0.00222	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000144	0.00221	CbGpPWpGaD
Alosetron—CYP2E1—nervous system—alcohol dependence	0.000143	0.0177	CbGeAlD
Alosetron—CYP3A4—blood—alcohol dependence	0.000141	0.0175	CbGeAlD
Alosetron—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000141	0.00217	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000139	0.00214	CbGpPWpGaD
Alosetron—CYP2E1—liver—alcohol dependence	0.000137	0.017	CbGeAlD
Alosetron—CYP2E1—central nervous system—alcohol dependence	0.000137	0.017	CbGeAlD
Alosetron—Vomiting—Citalopram—alcohol dependence	0.000137	0.00105	CcSEcCtD
Alosetron—Rash—Citalopram—alcohol dependence	0.000136	0.00104	CcSEcCtD
Alosetron—CYP2E1—Biological oxidations—ALDH2—alcohol dependence	0.000136	0.00209	CbGpPWpGaD
Alosetron—Dermatitis—Citalopram—alcohol dependence	0.000136	0.00104	CcSEcCtD
Alosetron—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000135	0.00208	CbGpPWpGaD
Alosetron—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000135	0.00208	CbGpPWpGaD
Alosetron—Headache—Citalopram—alcohol dependence	0.000135	0.00103	CcSEcCtD
Alosetron—CYP2E1—cerebellum—alcohol dependence	0.000134	0.0166	CbGeAlD
Alosetron—HTR3A—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000133	0.00204	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000132	0.00203	CbGpPWpGaD
Alosetron—Nausea—Citalopram—alcohol dependence	0.000128	0.000981	CcSEcCtD
Alosetron—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000127	0.00195	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000123	0.00189	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000123	0.00189	CbGpPWpGaD
Alosetron—CYP3A4—endocrine gland—alcohol dependence	0.000123	0.0152	CbGeAlD
Alosetron—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.00012	0.00184	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000118	0.00182	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000118	0.00182	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000117	0.0018	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000116	0.00178	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000115	0.00177	CbGpPWpGaD
Alosetron—CYP3A4—nervous system—alcohol dependence	0.000115	0.0142	CbGeAlD
Alosetron—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000112	0.00173	CbGpPWpGaD
Alosetron—CYP3A4—liver—alcohol dependence	0.00011	0.0137	CbGeAlD
Alosetron—CYP3A4—central nervous system—alcohol dependence	0.00011	0.0137	CbGeAlD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000109	0.00168	CbGpPWpGaD
Alosetron—CYP2E1—brain—alcohol dependence	0.000109	0.0135	CbGeAlD
Alosetron—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000102	0.00157	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000102	0.00157	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000102	0.00156	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000101	0.00155	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GGT1—alcohol dependence	9.95e-05	0.00153	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GGT2—alcohol dependence	9.76e-05	0.0015	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—MAOB—alcohol dependence	9.59e-05	0.00148	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	9.54e-05	0.00147	CbGpPWpGaD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.49e-05	0.00146	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	9.47e-05	0.00146	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	8.93e-05	0.00137	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—MAOA—alcohol dependence	8.92e-05	0.00137	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	8.15e-05	0.00125	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	8.11e-05	0.00125	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	7.79e-05	0.0012	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.69e-05	0.00118	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	7.63e-05	0.00117	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	7.52e-05	0.00116	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—MAOB—alcohol dependence	7.4e-05	0.00114	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GGT1—alcohol dependence	7e-05	0.00108	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	6.65e-05	0.00102	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	6.65e-05	0.00102	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	6.57e-05	0.00101	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	6.52e-05	0.001	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	6.43e-05	0.000989	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	6.29e-05	0.000968	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—MAOA—alcohol dependence	6.28e-05	0.000966	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADH6—alcohol dependence	6.27e-05	0.000964	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	6.26e-05	0.000963	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GGT1—alcohol dependence	5.98e-05	0.000921	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—POMC—alcohol dependence	5.81e-05	0.000894	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—MAOA—alcohol dependence	5.36e-05	0.000825	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADH1A—alcohol dependence	5.19e-05	0.000799	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.07e-05	0.000781	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	5.03e-05	0.000774	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	4.96e-05	0.000764	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GGT1—alcohol dependence	4.62e-05	0.000711	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADH4—alcohol dependence	4.42e-05	0.00068	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADH6—alcohol dependence	4.41e-05	0.000678	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.14e-05	0.000637	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—POMC—alcohol dependence	4.09e-05	0.000629	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADH6—alcohol dependence	3.77e-05	0.00058	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADH7—alcohol dependence	3.75e-05	0.000578	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADH1A—alcohol dependence	3.65e-05	0.000562	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GGT2—alcohol dependence	3.6e-05	0.000554	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—POMC—alcohol dependence	3.49e-05	0.000537	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADH1B—alcohol dependence	3.29e-05	0.000507	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADH1A—alcohol dependence	3.12e-05	0.00048	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADH4—alcohol dependence	3.11e-05	0.000478	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADH6—alcohol dependence	2.91e-05	0.000447	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MAOB—alcohol dependence	2.73e-05	0.00042	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.69e-05	0.000415	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.69e-05	0.000414	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADH4—alcohol dependence	2.65e-05	0.000408	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADH7—alcohol dependence	2.64e-05	0.000406	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GGT2—alcohol dependence	2.53e-05	0.00039	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.41e-05	0.000371	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALDH2—alcohol dependence	2.32e-05	0.000357	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADH1B—alcohol dependence	2.32e-05	0.000356	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.3e-05	0.000354	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADH7—alcohol dependence	2.26e-05	0.000347	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GGT2—alcohol dependence	2.16e-05	0.000333	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADH4—alcohol dependence	2.05e-05	0.000315	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADH1B—alcohol dependence	1.98e-05	0.000305	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT2—alcohol dependence	1.97e-05	0.000304	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MAOB—alcohol dependence	1.92e-05	0.000295	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADH7—alcohol dependence	1.74e-05	0.000268	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GGT1—alcohol dependence	1.7e-05	0.000262	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GOT1—alcohol dependence	1.7e-05	0.000262	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GGT2—alcohol dependence	1.67e-05	0.000257	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MAOB—alcohol dependence	1.64e-05	0.000252	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDH2—alcohol dependence	1.63e-05	0.000251	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.57e-05	0.000241	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.53e-05	0.000235	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MAOA—alcohol dependence	1.53e-05	0.000235	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.39e-05	0.000215	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT2—alcohol dependence	1.39e-05	0.000214	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.34e-05	0.000206	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.3e-05	0.000201	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAOB—alcohol dependence	1.27e-05	0.000195	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GGT1—alcohol dependence	1.2e-05	0.000184	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GOT1—alcohol dependence	1.2e-05	0.000184	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT2—alcohol dependence	1.19e-05	0.000182	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.11e-05	0.000172	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.08e-05	0.000166	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MAOA—alcohol dependence	1.07e-05	0.000165	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.04e-05	0.00016	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GGT1—alcohol dependence	1.02e-05	0.000157	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GOT1—alcohol dependence	1.02e-05	0.000157	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—POMC—alcohol dependence	9.93e-06	0.000153	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MAOA—alcohol dependence	9.17e-06	0.000141	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT2—alcohol dependence	9.15e-06	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.89e-06	0.000137	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2E1—alcohol dependence	8.6e-06	0.000132	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GOT1—alcohol dependence	7.9e-06	0.000122	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GGT1—alcohol dependence	7.9e-06	0.000122	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAOA—alcohol dependence	7.08e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—POMC—alcohol dependence	6.99e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—EP300—alcohol dependence	6.59e-06	0.000101	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—POMC—alcohol dependence	5.97e-06	9.19e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—EP300—alcohol dependence	4.64e-06	7.13e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—POMC—alcohol dependence	4.61e-06	7.09e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—EP300—alcohol dependence	3.96e-06	6.1e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—EP300—alcohol dependence	3.06e-06	4.7e-05	CbGpPWpGaD
